www.bioseedin.com Open in urlscan Pro
52.220.25.48  Public Scan

Submitted URL: https://r20.rs6.net/tn.jsp?f=001wuImBTObl3mUOJ643_lkbDiy85hAiRRDBgC6vOMuPMohYNesrxCcdXYtTJQZebKDigKxYM52j7v6sj0LML-b...
Effective URL: https://www.bioseedin.com/?utm_source=bioSeedin&utm_medium=CCnewsletter&utm_campaign=News&utm_content=website&utm_term=45239
Submission: On November 10 via manual from US — Scanned from DE

Form analysis 2 forms found in the DOM

<form class="el-form font enner w-full" data-v-5a471db7="">
  <div class="xl:px-0 el-row" style="margin-left:-6px;margin-right:-6px;" data-v-5a471db7="">
    <div class="el-col el-col-12 el-col-xs-24" style="padding-left:6px;padding-right:6px;" data-v-5a471db7="">
      <div placeholder="First name" class="el-form-item is-required" data-v-5a471db7=""><!---->
        <div class="el-form-item__content">
          <div class="bg el-input el-input--suffix" data-v-5a471db7=""><!----><input type="text" autocomplete="off" placeholder="First name" class="el-input__inner"><!----><!----><!----><!----></div><!---->
        </div>
      </div>
    </div>
    <div class="el-col el-col-12 el-col-xs-24" style="padding-left:6px;padding-right:6px;" data-v-5a471db7="">
      <div placeholder="Last name" class="el-form-item is-required" data-v-5a471db7=""><!---->
        <div class="el-form-item__content">
          <div class="bg el-input el-input--suffix" data-v-5a471db7=""><!----><input type="text" autocomplete="off" placeholder="Last name" class="el-input__inner"><!----><!----><!----><!----></div><!---->
        </div>
      </div>
    </div>
  </div>
  <div placeholder="Email" class="el-form-item xl:px-0 is-required" data-v-5a471db7=""><!---->
    <div class="el-form-item__content">
      <div class="bg el-input el-input--suffix" data-v-5a471db7=""><!----><input type="text" autocomplete="off" placeholder="Email" class="el-input__inner"><!----><!----><!----><!----></div><!---->
    </div>
  </div>
  <div class="el-form-item xl:px-0" data-v-5a471db7=""><!---->
    <div class="el-form-item__content">
      <div class="el-textarea el-input--suffix" data-v-5a471db7=""><textarea autocomplete="off" placeholder="Message(option)" class="el-textarea__inner" style="min-height: 33px;"></textarea><!----></div><!---->
    </div>
  </div>
  <div class="el-form-item xl:px-0" data-v-5a471db7=""><!---->
    <div class="el-form-item__content">
      <div class="checkBox flex items-center" data-v-164beb8a="" data-v-5a471db7="">
        <div class="border-2 cursor-pointer select-box" style="border-color:#76A72D;" data-v-164beb8a="">
          <div class="content" style="width:8px;height:8px;margin:4px;background:#76A72D;visibility:visible;" data-v-164beb8a=""></div>
        </div>
        <div class="pl-4 label" data-v-164beb8a=""> Subscribe newsletter </div>
      </div><!---->
    </div>
  </div>
  <div class="el-form-item xl:px-0" data-v-5a471db7=""><!---->
    <div class="el-form-item__content"><button type="button" class="el-button el-button--primary" style="width:100%;" data-v-5a471db7=""><!----><!----><span> Submit </span></button><!----></div>
  </div>
</form>

<form data-v-d34cdf68="" class="el-form">
  <div data-v-d34cdf68="" class="el-row" style="margin-left: -6px; margin-right: -6px;">
    <div data-v-d34cdf68="" class="el-col el-col-12 el-col-xs-24" style="padding-left: 6px; padding-right: 6px;">
      <div data-v-d34cdf68="" class="el-form-item is-required" placeholder="First name"><!---->
        <div class="el-form-item__content">
          <div data-v-d34cdf68="" class="bg el-input el-input--suffix"><!----><input type="text" autocomplete="off" placeholder="First name" class="el-input__inner"><!----><!----><!----><!----></div><!---->
        </div>
      </div>
    </div>
    <div data-v-d34cdf68="" class="el-col el-col-12 el-col-xs-24" style="padding-left: 6px; padding-right: 6px;">
      <div data-v-d34cdf68="" class="el-form-item is-required" placeholder="Last name"><!---->
        <div class="el-form-item__content">
          <div data-v-d34cdf68="" class="bg el-input el-input--suffix"><!----><input type="text" autocomplete="off" placeholder="Last name" class="el-input__inner"><!----><!----><!----><!----></div><!---->
        </div>
      </div>
    </div>
  </div>
  <div data-v-d34cdf68="" class="el-form-item mt-5 is-required" placeholder="Email"><!---->
    <div class="el-form-item__content">
      <div data-v-d34cdf68="" class="bg el-input el-input--suffix"><!----><input type="text" autocomplete="off" placeholder="Email" class="el-input__inner"><!----><!----><!----><!----></div><!---->
    </div>
  </div>
  <div data-v-d34cdf68="" class="el-form-item mt-3"><!---->
    <div class="el-form-item__content">
      <div data-v-d34cdf68="" class="flex items-end">
        <div data-v-d34cdf68="" class="flex items-baseline cursor-auto" style="color: rgb(140, 156, 118); font-size: 16px;"> or sign in with <img data-v-d34cdf68="" src="/_nuxt/img/google.5444bfe.svg" alt="" class="w-4 h-4 ml-5 cursor-pointer"
            style="transform: translateY(9%);"> <img data-v-d34cdf68="" src="/_nuxt/img/likins.b966faa.svg" alt="" class="w-4 h-4 ml-5 cursor-pointer"></div>
      </div><!---->
    </div>
  </div>
  <div data-v-d34cdf68="" class="el-form-item mt-3"><!---->
    <div class="el-form-item__content">
      <div data-v-d34cdf68="" class="el-textarea el-input--suffix"><textarea autocomplete="off" placeholder="Message(option)" class="el-textarea__inner" style="min-height: 33px;"></textarea><!----></div><!---->
    </div>
  </div>
  <div data-v-d34cdf68="" class="el-form-item mt-5"><!---->
    <div class="el-form-item__content">
      <div data-v-164beb8a="" data-v-d34cdf68="" class="checkBox flex items-center" style="color: rgb(40, 66, 2);">
        <div data-v-164beb8a="" class="border-2 cursor-pointer select-box" style="border-color: rgb(40, 66, 2);">
          <div data-v-164beb8a="" class="content" style="width: 8px; height: 8px; margin: 4px; background: rgb(40, 66, 2); visibility: visible;"></div>
        </div>
        <div data-v-164beb8a="" class="pl-4 label"> Subscribe newsletter </div>
      </div><!---->
    </div>
  </div>
  <div data-v-d34cdf68="" class="el-form-item mt-5" style="margin-bottom: 1.75rem;"><!---->
    <div class="el-form-item__content"><button data-v-d34cdf68="" type="button" class="el-button el-button--primary" style="width: 100%; background: rgb(165, 222, 80); color: rgb(40, 66, 2);"><!----><!----><span> Submit </span></button><!----></div>
  </div>
</form>

Text Content

HOME
ABOUT US
LICENSING
EVENTS
CONTACT US
Login
Register
English
Chinese
Login
Login
 * HOME
 * ABOUT US
 * LICENSING
 * EVENTS
 * CONTACT US


Time always matters
Connecting your promising therapeutic with our global partners and resources
WHAT WE DO
We provide asset management services via licensing in and out, co-developmental
partner sourcing, and project implementation, as well as advising on public
relation management, Asia market entry, investment strategy, mergers and
acquisitions, and capital raising.
8,032
Biopharma Client
403,251
End-User Database
78
Countries Covered
144,625
Scientists
8,032
Biopharma Client
403,251
End-User Database
78
Countries Covered
144,625
Scientists
8,032
Biopharma Client
403,251
End-User Database
78
Countries Covered
144,625
Scientists
Recommendation
More

Project Name
Area
Indication
PCC
Preclinical
IND
Phase I
Phase II
Phase III
NDA/BLA
ProjectStage
Dual Orexin Receptor Antagonist
Neurological disease
Insomnia Disorder


CLDN18.2/CD8+T bsAb
Oncology/Cancer
Gastric cancer,Pancreatic cancer,Oophoroma


Trop-2 ADC
Oncology/Cancer
Gastric cancer,Pancreatic cancer


Sirpa/PD1 bsAb
Oncology/Cancer
Advanced solid tumor


BAFFR/CD3 bsAb
Oncology/Cancer
B-cell lymphoma


Project Name
Area
Indication
ProjectStage

Dual Orexin Receptor Antagonist
Neurological disease
Insomnia Disorder
Phase III
CLDN18.2/CD8+T bsAb
Oncology/Cancer
Gastric cancerPancreatic cancerOophoroma
IND
Trop-2 ADC
Oncology/Cancer
Gastric cancerPancreatic cancer
IND
Sirpa/PD1 bsAb
Oncology/Cancer
Advanced solid tumor
Preclinical
BAFFR/CD3 bsAb
Oncology/Cancer
B-cell lymphoma
Preclinical

Project Name
Area
Indication
ProjectStage

Dual Orexin Receptor Antagonist
Neurological disease
Insomnia Disorder
Phase III
CLDN18.2/CD8+T bsAb
Oncology/Cancer
Gastric cancerPancreatic cancerOophoroma
IND
Trop-2 ADC
Oncology/Cancer
Gastric cancerPancreatic cancer
IND
Sirpa/PD1 bsAb
Oncology/Cancer
Advanced solid tumor
Preclinical
BAFFR/CD3 bsAb
Oncology/Cancer
B-cell lymphoma
Preclinical


Boston
|
San Jose
|
Newark
|
Frankfurt
London
|
Basel
|
Beijing
|
Shanghai


Hangzhou
|
Suzhou
Stay Connected and Get Updates
Subscribe newsletter
Submit
Leave a message

or sign in with

Subscribe newsletter
Submit